Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11524075 Animal protein-free pharmaceutical compositions

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Allergan, Inc.
Allergan, Inc.
Date Filed
June 28, 2022
Date of Patent
December 13, 2022
Patent Applicant
Allergan, Inc.
Allergan, Inc.
Patent Application Number
17852211
Patent Citations
‌
US Patent 10369190 Non-protein clostridial toxin compositions
‌
US Patent 10465178 Process and system for obtaining botulinum neurotoxin
‌
US Patent 10549042 Botulinum toxin prefilled glass syringe
‌
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
‌
US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins
‌
US Patent 10744202 Sustained release eye drop formulations
‌
US Patent 10946030 Formulations of deoxycholic acid and salts thereof
‌
US Patent 11033625 Method for stabilizing a toxin
‌
US Patent 11124786 Process and system for obtaining botulinum neurotoxin
‌
US Patent 11285216 Animal protein-free pharmaceutical compositions
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11524075
Patent Primary Examiner
‌
Jennifer E. Graser

Find more entities like US Patent 11524075 Animal protein-free pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.